echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > Increased squeeze competition?

    Increased squeeze competition?

    • Last Update: 2021-08-14
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    810 ,DTP:,DTP;,,DTP
    。,“”
    。DTP:,,,?
     
    ,,DTP10,
    。DTP,DTP
     
    DTPVS
     
    DTP!
     
    ,DTP
    。、、、,、、
     
    According to the definition of the "National Specialty Drug Association" in the US market where the specialty drug market is more developed, DTP pharmacy refers to a national licensed pharmacy that only provides or mainly provides drugs for patients with serious health problems that require complex treatment
    .
    The U.
    S.
    Medicare insurance plan in 2019 also more specifically defined one of the characteristics of specialty drugs as "the minimum monthly expenditure is $670"
    .
     
    If specialty drugs are easily sold through ordinary pharmacies, then there will be no such special form of pharmacies as DTP pharmacies
    .
     
    Five core values: DTP is a special form of pharmacy
     
    To sum up, the core values ​​of DTP pharmacy have the following points:
     
    ① High professional requirements Special drugs are not ordinary drugs.
    Due to the complexity of the disease itself, there are high requirements for the professionalism of the pharmacy itself
    .
    Many specialty drugs have adverse reactions.
    The monitoring of adverse reactions, patient medication education and question answering, and patient medication monitoring are all key tasks for pharmacies
    .
     
    ②Infusion service Many specialty medicines require injection or infusion, which requires DTP pharmacies to provide corresponding services
    .
     
      ③Strong storage capacity Specialty drugs often have high requirements for storage, and many require cold chain logistics and low-temperature storage, which also puts forward specific hardware and supply chain requirements for specialty drug stores
    .
     
      ④ Pay more attention to privacy Special medicines often target special diseases or major diseases.
    For patients, most of these diseases do not want more people to know, so the privacy protection of patients pays more attention than ordinary pharmacies
    .
     
      ⑤Various innovative payment methods and special medicines are expensive, and many patients have problems with their ability to pay.
    Therefore, cooperation with charity funds and pharmaceutical companies to provide patients with economic or financial assistance is also an important value for special medicine pharmacies.
    One
    .
     
      Do general pharmacies do DTP ? More independent operation for DTP
     
      The main positioning of ordinary pharmacies is the sale of non-prescription drugs, medical equipment , health care products , commonly used prescription drugs, etc.
    , with different requirements for venues, personnel, and corresponding support systems
    .
    If two different models are combined to provide services in the same store, it is feasible for some large stores with thousands of square meters or super-large pharmaceutical cities; but for ordinary stores of more than 100 square meters, it is not financially cost-effective.
    Nor can it guarantee the necessary services for patients taking special medicines
    .
     
      Therefore, although some general pharmacies also offer special drugs for sale, and some DTP pharmacies also sell general drugs, the two pharmacies have their own value independently
    .
    As mentioned earlier, even if manufacturers bundle DTP products together to make the cooperation with chain pharmacies bigger and stronger, many chain pharmacies also choose to sell these products through DTP pharmacies alone.
    For example, there are 143 DTP pharmacies under the general public’s pharmacy.
    There are more than 40 Yifeng pharmacies and 89 Dashenlin
    .
     
      E-commerce threat? The value provided by DTP cannot be achieved by e-commerce
     
       The "Internet medical enterprise threat" also has a similar logic
    .
    Although pharmaceutical e-commerce companies also sell some specialty drugs, the nature of this is just like that of ordinary pharmacies in DTP pharmacies: the value provided by DTP pharmacies cannot be provided by pharmaceutical e-commerce companies.
    Therefore, Internet pharmaceutical e-commerce companies do not constitute a tribute to DTP pharmacies.
    Threatened
    .
     
      In fact, some medical big data companies are optimistic about the DTP pharmacy market, and they have deployed their own DTP pharmacies offline, such as Linke under Zerokrypton Technology and Sipai Pharmacy under Sipai.
    com
    .
     
      DTP Pharmacy VS Hospital
     
      Who is the leader?
     
      On the other hand, DTP pharmacy practitioners are generally concerned about competition from hospitals
    .
    This view believes that special drugs enter the hospital after the success of medical insurance, leading the hospital to seize the DTP pharmacy market
    .
    The author believes that this issue should be viewed from both short-term and long-term perspectives
    .
     
      DTP encounters phased challenges, but long-term benefits
     
      In the short term, this kind of competition exists objectively.
    If a drug is sold in hospitals and DTP pharmacies at the same time, it is more likely for patients to choose to buy in hospitals, especially when patients buy drugs while also requiring biochemicals.
    In the case of examinations such as, pathology, etc.
    , only hospitals can provide one-stop services
    .
    However, there are some considerations for this policy: the varieties of the "dual channel" policy are basically adopted in the designation of designated medical insurance institutions in the same city, and there are only designated medical institutions or designated pharmacies in the same city; another aspects, in the context of zero difference medicine, hospital medicine sales special medicines power and inadequate, these are good DTP pharmacy
    .
     
      In the long run, with the continuous promotion of the medical separation policy, there will be no competitive relationship between hospitals and pharmacies, and DTP pharmacies
    .
    The drug sales function of hospitals will gradually be stripped off.
    Community health centers, retail pharmacies, etc.
    will provide drug sales and basic services.
    Hospitals will focus more on disease diagnosis, provision of treatment plans, and hospitalization services
    .
    The current competition for DTP pharmacies is only a staged challenge encountered during the transitional period of market development
    .
     
    Four   current DTP challenges
     
      So, in the short term, we have already talked about how DTP pharmacies face this kind of challenge with hospitals
    .
    The author summarizes 4 points:
     
      ①Strengthen the introduction of varieties In addition to anti-tumor drugs, the introduction of hepatitis C/hepatitis B, hematological diseases, autoimmune system diseases, and rare drugs will be strengthened to enhance the profitability of DTP pharmacies
    .
     
      ②Improve the level of pharmaceutical services.
    Strengthen the training and improvement of pharmacists' professional service capabilities, combine medical big data, artificial intelligence, Internet medical technology and other technologies, connect pharmaceutical companies, hospitals, doctors, etc.
    , to provide patients with follow-up, rehabilitation, medication guidance and other services
    .
     
      ③Cooperate with industrial enterprises to carry out patient education.
    Improve the influence of DTP pharmacies on patients and establish the brand power of DTP pharmacies through projects such as live broadcast of famous doctors and charity medication
    .
     
      ④ Carry out the construction of infusion centers, etc.
    Provide infusion services for drug injection patients through joint hospitals and self-built methods, so as to expand the sales of injection drugs in DTP pharmacies
    .
     
      DTP future outlook
     
      Benchmarking to the United States, DTP has a lot of room for expansion
     
      In fact, in addition to the long-term benefits brought about by the continuous advancement of the pharmaceutical separation policy, the DTP pharmacy market is also facing unprecedented opportunities brought about by the development of the pharmaceutical market
    .
    As the research and development of market products such as drugs for chronic diseases gradually stabilizes, the main battlefield of future innovative drug research and development has shifted to the research and development of oncology drugs and rare drugs, which will inject continuous impetus into the DTP pharmacy market
    .
    Take the very mature American market for specialty drug pharmacies (the United States is not called DTP pharmacy, but specialty drug pharmacy) as an example, which can provide us with a good reference
    .
     
      As we all know, the US market has long been a market driven by innovative drugs.
    On the second day of the expiration of the patent protection period of all drugs, the price of all drugs will fall off a cliff due to the entry of generic drugs
    .
    China's pharmaceutical market is also changing to such a market
    .
    Driven by policies such as one-off evaluation of generic drugs and mass procurement, a pattern dominated by innovative drugs is taking shape
    .
    At the same time, the U.
    S.
    market is also a market for the separation of medicines.
    About 80% of the sales of medicines are done through retail channels.
    The separation of medicines is also an important direction for China's medical reform
    .
    Benchmarking the development of the US market has a relatively important reference for the development of China's DTP market
    .
     
      U.
    S.
    specialty medicines account for half of revenue, while China accounts for less than 4%
     
      In 2020, the overall U.
    S.
    retail pharmacy market’s operating revenue was US$319.
    3 billion, of which nearly half came from specialty drug pharmacies.
    Table 1 shows the revenue of TOP15 specialty drug pharmacies in the U.
    S.
    market in 2019, which adds up to US$135.
    5 billion, accounting for More than 80% of the entire specialty medicine market (also ordinary retail stores, mailing pharmacies, long-term care institutions and other channels)
    .
    The annual growth rate of the US specialty drug pharmacy market is about 5%, which is twice the growth rate of the general pharmacy market
    .
     
      The vigorous development of the specialty drug pharmacy market in the United States and the similar environment give us reason to believe in the future development prospects of the Chinese DTP pharmacy market
    .
    Although China's DTP pharmacy market is currently only about 19 billion yuan in scale, accounting for less than 4% of the overall pharmaceutical retail market, it has received extensive attention from the market
    .
     
      By 2024, China's DTP market will double again
     
      According to the estimation of Frost & Sullivan, a well-known consulting company, China's DTP market will grow to 38.
    3 billion yuan by 2024, and the growth rate is significantly higher than that of ordinary pharmaceutical retail
    .
    Figure 1 shows Frost & Sullivan's estimate of the DTP market size
    .
     
      Conclusion <<<
     
      The future is bright, and the road is tortuous
    .
    In the face of the promising DTP market, DTP practitioners should not encounter some small challenges and worry about nothing
    .
    When encountering a problem, it is necessary to analyze the problem and solve the problem, make a long-term plan, and gain a larger share in the future potential DTP market
    .
      Medical Network News on August 10th.
    After the establishment of the National Medical Insurance Bureau, the implementation of the two policies of National Talks and Centralized Procurement has had a huge impact on traditional DTP pharmacies: National Talks made new special drugs enter the hospital after the price cuts, and left DTP pharmacies.
    ; Centralized procurement makes abandoned drugs enter chain pharmacies.
    In order to help these drugs better market, large pharmaceutical companies will bundle DTP products together to make the cooperation with chain pharmacies bigger and stronger
    .
    In addition, the "air competition" of Internet medical treatment has stripped away a part of the market
    .
    Many traditional DTP pharmacies are in confusion: in terms of professionalism, they are inferior to hospital pharmacies, in terms of convenience, inferior to chain pharmacies, and in terms of technology, inferior to Internet medical services.
    How should the future be?
     
      The author believes that this confusion may be a false proposition.
    DTP pharmacy is a new business format that has only been developed in the past 10 years.
    It originally took away the business that originally belonged to hospitals and ordinary retail pharmacies through differentiated positioning in the market segment
    .
    If DTP pharmacies want to break the mystery of this false proposition, they must first return to understanding the core values ​​and core positioning of DTP pharmacies
    .
     
      DTP Pharmacy VS General Pharmacy
     
      Look at the core value of DTP !
     
      According to the definition of China Pharmaceutical Business Association, DTP pharmacies mainly sell medicines for the treatment of certain special diseases or major diseases
    .
    These drugs often have definite curative effects, high treatment costs, special medication monitoring, special storage and transportation requirements, etc.
    , such as infliximab for the treatment of rheumatoid arthritis, rituximab injection for the treatment of lymphoma, treatment Ositinib mesylate tablets and other drugs for lung cancer
    .
     
      According to the definition of the "National Specialty Drug Association" in the US market where the specialty drug market is more developed, DTP pharmacy refers to a national licensed pharmacy that only provides or mainly provides drugs for patients with serious health problems that require complex treatment
    .
    The U.
    S.
    Medicare insurance plan in 2019 also more specifically defined one of the characteristics of specialty drugs as "the minimum monthly expenditure is $670"
    .
     
      If specialty drugs are easily sold through ordinary pharmacies, then there will be no such special form of pharmacies as DTP pharmacies
    .
     
      Five core values: DTP is a special form of pharmacy
     
      To sum up, the core values ​​of DTP pharmacy have the following points:
     
      ① High professional requirements Special drugs are not ordinary drugs.
    Due to the complexity of the disease itself, there are high requirements for the professionalism of the pharmacy itself
    .
    Many specialty drugs have adverse reactions.
    The monitoring of adverse reactions, patient medication education and question answering, and patient medication monitoring are all key tasks for pharmacies
    .
     
      ②Infusion service Many specialty medicines require injection or infusion, which requires DTP pharmacies to provide corresponding services
    .
     
      ③Strong storage capacity Specialty drugs often have high requirements for storage, and many require cold chain logistics and low-temperature storage, which also puts forward specific hardware and supply chain requirements for specialty drug stores
    .
     
      ④ Pay more attention to privacy Special medicines often target special diseases or major diseases.
    For patients, most of these diseases do not want more people to know, so the privacy protection of patients pays more attention than ordinary pharmacies
    .
     
      ⑤Various innovative payment methods and special medicines are expensive, and many patients have problems with their ability to pay.
    Therefore, cooperation with charity funds and pharmaceutical companies to provide patients with economic or financial assistance is also an important value for special medicine pharmacies.
    One
    .
     
      Do general pharmacies do DTP ? More independent operation for DTP
     
      The main positioning of ordinary pharmacies is the sale of non-prescription drugs, medical equipment , health care products , commonly used prescription drugs, etc.
    , with different requirements for venues, personnel, and corresponding support systems
    .
    If two different models are combined to provide services in the same store, it is feasible for some large stores with thousands of square meters or super-large pharmaceutical cities; but for ordinary stores of more than 100 square meters, it is not financially cost-effective.
    Nor can it guarantee the necessary services for patients taking special medicines
    .
     
      Therefore, although some general pharmacies also offer special drugs for sale, and some DTP pharmacies also sell general drugs, the two pharmacies have their own value independently
    .
    As mentioned earlier, even if manufacturers bundle DTP products together to make the cooperation with chain pharmacies bigger and stronger, many chain pharmacies also choose to sell these products through DTP pharmacies alone.
    For example, there are 143 DTP pharmacies under the general public’s pharmacy.
    There are more than 40 Yifeng pharmacies and 89 Dashenlin
    .
     
      E-commerce threat? The value provided by DTP cannot be achieved by e-commerce
     
       The "Internet medical enterprise threat" also has a similar logic
    .
    Although pharmaceutical e-commerce companies also sell some specialty drugs, the nature of this is just like that of ordinary pharmacies in DTP pharmacies: the value provided by DTP pharmacies cannot be provided by pharmaceutical e-commerce companies.
    Therefore, Internet pharmaceutical e-commerce companies do not constitute a tribute to DTP pharmacies.
    Threatened
    .
     
      In fact, some medical big data companies are optimistic about the DTP pharmacy market, and they have deployed their own DTP pharmacies offline, such as Linke under Zerokrypton Technology and Sipai Pharmacy under Sipai.
    com
    .
     
      DTP Pharmacy VS Hospital
     
      Who is the leader?
     
      On the other hand, DTP pharmacy practitioners are generally concerned about competition from hospitals
    .
    This view believes that special drugs enter the hospital after the success of medical insurance, leading the hospital to seize the DTP pharmacy market
    .
    The author believes that this issue should be viewed from both short-term and long-term perspectives
    .
     
      DTP encounters phased challenges, but long-term benefits
     
      In the short term, this kind of competition exists objectively.
    If a drug is sold in hospitals and DTP pharmacies at the same time, it is more likely for patients to choose to buy in hospitals, especially when patients buy drugs while also requiring biochemicals.
    In the case of examinations such as, pathology, etc.
    , only hospitals can provide one-stop services
    .
    However, there are some considerations for this policy: the varieties of the "dual channel" policy are basically adopted in the designation of designated medical insurance institutions in the same city, and there are only designated medical institutions or designated pharmacies in the same city; another aspects, in the context of zero difference medicine, hospital medicine sales special medicines power and inadequate, these are good DTP pharmacy
    .
     
      In the long run, with the continuous promotion of the medical separation policy, there will be no competitive relationship between hospitals and pharmacies, and DTP pharmacies
    .
    The drug sales function of hospitals will gradually be stripped off.
    Community health centers, retail pharmacies, etc.
    will provide drug sales and basic services.
    Hospitals will focus more on disease diagnosis, provision of treatment plans, and hospitalization services
    .
    The current competition for DTP pharmacies is only a staged challenge encountered during the transitional period of market development
    .
     
    Four   current DTP challenges
     
      So, in the short term, we have already talked about how DTP pharmacies face this kind of challenge with hospitals
    .
    The author summarizes 4 points:
     
      ①Strengthen the introduction of varieties In addition to anti-tumor drugs, the introduction of hepatitis C/hepatitis B, hematological diseases, autoimmune system diseases, and rare drugs will be strengthened to enhance the profitability of DTP pharmacies
    .
     
      ②Improve the level of pharmaceutical services.
    Strengthen the training and improvement of pharmacists' professional service capabilities, combine medical big data, artificial intelligence, Internet medical technology and other technologies, connect pharmaceutical companies, hospitals, doctors, etc.
    , to provide patients with follow-up, rehabilitation, medication guidance and other services
    .
     
      ③Cooperate with industrial enterprises to carry out patient education.
    Improve the influence of DTP pharmacies on patients and establish the brand power of DTP pharmacies through projects such as live broadcast of famous doctors and charity medication
    .
     
      ④ Carry out the construction of infusion centers, etc.
    Provide infusion services for drug injection patients through joint hospitals and self-built methods, so as to expand the sales of injection drugs in DTP pharmacies
    .
     
      DTP future outlook
     
      Benchmarking to the United States, DTP has a lot of room for expansion
     
      In fact, in addition to the long-term benefits brought about by the continuous advancement of the pharmaceutical separation policy, the DTP pharmacy market is also facing unprecedented opportunities brought about by the development of the pharmaceutical market
    .
    As the research and development of market products such as drugs for chronic diseases gradually stabilizes, the main battlefield of future innovative drug research and development has shifted to the research and development of oncology drugs and rare drugs, which will inject continuous impetus into the DTP pharmacy market
    .
    Take the very mature American market for specialty drug pharmacies (the United States is not called DTP pharmacy, but specialty drug pharmacy) as an example, which can provide us with a good reference
    .
     
      As we all know, the US market has long been a market driven by innovative drugs.
    On the second day of the expiration of the patent protection period of all drugs, the price of all drugs will fall off a cliff due to the entry of generic drugs
    .
    China's pharmaceutical market is also changing to such a market
    .
    Driven by policies such as one-off evaluation of generic drugs and mass procurement, a pattern dominated by innovative drugs is taking shape
    .
    At the same time, the U.
    S.
    market is also a market for the separation of medicines.
    About 80% of the sales of medicines are done through retail channels.
    The separation of medicines is also an important direction for China's medical reform
    .
    Benchmarking the development of the US market has a relatively important reference for the development of China's DTP market
    .
     
      U.
    S.
    specialty medicines account for half of revenue, while China accounts for less than 4%
     
      In 2020, the overall U.
    S.
    retail pharmacy market’s operating revenue was US$319.
    3 billion, of which nearly half came from specialty drug pharmacies.
    Table 1 shows the revenue of TOP15 specialty drug pharmacies in the U.
    S.
    market in 2019, which adds up to US$135.
    5 billion, accounting for More than 80% of the entire specialty medicine market (also ordinary retail stores, mailing pharmacies, long-term care institutions and other channels)
    .
    The annual growth rate of the US specialty drug pharmacy market is about 5%, which is twice the growth rate of the general pharmacy market
    .
     
      The vigorous development of the specialty drug pharmacy market in the United States and the similar environment give us reason to believe in the future development prospects of the Chinese DTP pharmacy market
    .
    Although China's DTP pharmacy market is currently only about 19 billion yuan in scale, accounting for less than 4% of the overall pharmaceutical retail market, it has received extensive attention from the market
    .
     
      By 2024, China's DTP market will double again
     
      According to the estimation of Frost & Sullivan, a well-known consulting company, China's DTP market will grow to 38.
    3 billion yuan by 2024, and the growth rate is significantly higher than that of ordinary pharmaceutical retail
    .
    Figure 1 shows Frost & Sullivan's estimate of the DTP market size
    .
     
      Conclusion <<<
     
      The future is bright, and the road is tortuous
    .
    In the face of the promising DTP market, DTP practitioners should not encounter some small challenges and worry about nothing
    .
    When encountering a problem, it is necessary to analyze the problem and solve the problem, make a long-term plan, and gain a larger share in the future potential DTP market
    .
      Medical Network News on August 10th.
    After the establishment of the National Medical Insurance Bureau, the implementation of the two policies of National Talks and Centralized Procurement has had a huge impact on traditional DTP pharmacies: National Talks made new special drugs enter the hospital after the price cuts, and left DTP pharmacies.
    ; Centralized procurement makes abandoned drugs enter chain pharmacies.
    In order to help these drugs better market, large pharmaceutical companies will bundle DTP products together to make the cooperation with chain pharmacies bigger and stronger
    .
    In addition, the "air competition" of Internet medical treatment has stripped away a part of the market
    .
    Many traditional DTP pharmacies are in confusion: in terms of professionalism, they are inferior to hospital pharmacies, in terms of convenience, inferior to chain pharmacies, and in terms of technology, inferior to Internet medical services.
    How should the future be?
     
      The author believes that this confusion may be a false proposition.
    DTP pharmacy is a new business format that has only been developed in the past 10 years.
    It originally took away the business that originally belonged to hospitals and ordinary retail pharmacies through differentiated positioning in the market segment
    .
    If DTP pharmacies want to break the mystery of this false proposition, they must first return to understanding the core values ​​and core positioning of DTP pharmacies
    .
     
      DTP Pharmacy VS General Pharmacy
      DTP Pharmacy VS General Pharmacy
     
      Look at the core value of DTP !
      Look at the core value of DTP !
     
      According to the definition of China Pharmaceutical Business Association, DTP pharmacies mainly sell medicines for the treatment of certain special diseases or major diseases
    .
    These drugs often have definite curative effects, high treatment costs, special medication monitoring, special storage and transportation requirements, etc.
    , such as infliximab for the treatment of rheumatoid arthritis, rituximab injection for the treatment of lymphoma, treatment Ositinib mesylate tablets and other drugs for lung cancer
    .
     
      According to the definition of the "National Specialty Drug Association" in the US market where the specialty drug market is more developed, DTP pharmacy refers to a national licensed pharmacy that only provides or mainly provides drugs for patients with serious health problems that require complex treatment
    .
    The U.
    S.
    Medicare insurance plan in 2019 also more specifically defined one of the characteristics of specialty drugs as "the minimum monthly expenditure is $670"
    .
     
      If specialty drugs are easily sold through ordinary pharmacies, then there will be no such special form of pharmacies as DTP pharmacies
    .
     
      Five core values: DTP is a special form of pharmacy
      Five core values: DTP is a special form of pharmacy
     
      To sum up, the core values ​​of DTP pharmacy have the following points:
     
      ① High professional requirements Special drugs are not ordinary drugs.
    Due to the complexity of the disease itself, there are high requirements for the professionalism of the pharmacy itself
    .
    Many specialty drugs have adverse reactions.
    The monitoring of adverse reactions, patient medication education and question answering, and patient medication monitoring are all key tasks for pharmacies
    .
     
      ②Infusion service Many specialty medicines require injection or infusion, which requires DTP pharmacies to provide corresponding services
    .
     
      ③Strong storage capacity Specialty drugs often have high requirements for storage, and many require cold chain logistics and low-temperature storage, which also puts forward specific hardware and supply chain requirements for specialty drug stores
    .
     
      ④ Pay more attention to privacy Special medicines often target special diseases or major diseases.
    For patients, most of these diseases do not want more people to know, so the privacy protection of patients pays more attention than ordinary pharmacies
    .
     
      ⑤Various innovative payment methods and special medicines are expensive, and many patients have problems with their ability to pay.
    Therefore, cooperation with charity funds and pharmaceutical companies to provide patients with economic or financial assistance is also an important value for special medicine pharmacies.
    One
    .
     
      Do general pharmacies do DTP ? More independent operation for DTP
      Do general pharmacies do DTP ? More independent operation for DTP
     
      The main positioning of ordinary pharmacies is the sale of non-prescription drugs, medical equipment , health care products , commonly used prescription drugs, etc.
    , with different requirements for venues, personnel, and corresponding support systems
    .
    If two different models are combined to provide services in the same store, it is feasible for some large stores with thousands of square meters or super-large pharmaceutical cities; but for ordinary stores of more than 100 square meters, it is not financially cost-effective.
    Nor can it guarantee the necessary services for patients taking special medicines
    .
    Medical equipment, medical equipment, medical equipment, health products, health products, health products
     
      Therefore, although some general pharmacies also offer special drugs for sale, and some DTP pharmacies also sell general drugs, the two pharmacies have their own value independently
    .
    As mentioned earlier, even if manufacturers bundle DTP products together to make the cooperation with chain pharmacies bigger and stronger, many chain pharmacies also choose to sell these products through DTP pharmacies alone.
    For example, there are 143 DTP pharmacies under the general public’s pharmacy.
    There are more than 40 Yifeng pharmacies and 89 Dashenlin
    .
     
      E-commerce threat? The value provided by DTP cannot be achieved by e-commerce
     
       The "Internet medical enterprise threat" also has a similar logic
    .
    Although pharmaceutical e-commerce companies also sell some specialty drugs, the nature of this is just like that of ordinary pharmacies in DTP pharmacies: the value provided by DTP pharmacies cannot be provided by pharmaceutical e-commerce companies.
    Therefore, Internet pharmaceutical e-commerce companies do not constitute a tribute to DTP pharmacies.
    Threatened
    .
    Enterprise business enterprise
     
      In fact, some medical big data companies are optimistic about the DTP pharmacy market, and they have deployed their own DTP pharmacies offline, such as Linke under Zerokrypton Technology and Sipai Pharmacy under Sipai.
    com
    .
     
      DTP Pharmacy VS Hospital
      DTP Pharmacy VS Hospital
     
      Who is the leader?
      Who is the leader?
     
      On the other hand, DTP pharmacy practitioners are generally concerned about competition from hospitals
    .
    This view believes that special drugs enter the hospital after the success of medical insurance, leading the hospital to seize the DTP pharmacy market
    .
    The author believes that this issue should be viewed from both short-term and long-term perspectives
    .
     
      DTP encounters phased challenges, but long-term benefits
      DTP encounters phased challenges, but long-term benefits
     
      In the short term, this kind of competition exists objectively.
    If a drug is sold in hospitals and DTP pharmacies at the same time, it is more likely for patients to choose to buy in hospitals, especially when patients buy drugs while also requiring biochemicals.
    In the case of examinations such as, pathology, etc.
    , only hospitals can provide one-stop services
    .
    However, there are some considerations for this policy: the varieties of the "dual channel" policy are basically adopted in the designation of designated medical insurance institutions in the same city, and there are only designated medical institutions or designated pharmacies in the same city; another aspects, in the context of zero difference medicine, hospital medicine sales special medicines power and inadequate, these are good DTP pharmacy
    .
    Medicine, medicine, medicine
     
      In the long run, with the continuous promotion of the medical separation policy, there will be no competitive relationship between hospitals and pharmacies, and DTP pharmacies
    .
    The drug sales function of hospitals will gradually be stripped off.
    Community health centers, retail pharmacies, etc.
    will provide drug sales and basic services.
    Hospitals will focus more on disease diagnosis, provision of treatment plans, and hospitalization services
    .
    The current competition for DTP pharmacies is only a staged challenge encountered during the transitional period of market development
    .
    Medicine Medicine Medicine
     
    Four   current DTP challenges
    Four   current DTP challenges
     
      So, in the short term, we have already talked about how DTP pharmacies face this kind of challenge with hospitals
    .
    The author summarizes 4 points:
     
      ①Strengthen the introduction of varieties In addition to anti-tumor drugs, the introduction of hepatitis C/hepatitis B, hematological diseases, autoimmune system diseases, and rare drugs will be strengthened to enhance the profitability of DTP pharmacies
    .
     
      ②Improve the level of pharmaceutical services.
    Strengthen the training and improvement of pharmacists' professional service capabilities, combine medical big data, artificial intelligence, Internet medical technology and other technologies, connect pharmaceutical companies, hospitals, doctors, etc.
    , to provide patients with follow-up, rehabilitation, medication guidance and other services
    .
     
      ③Cooperate with industrial enterprises to carry out patient education.
    Improve the influence of DTP pharmacies on patients and establish the brand power of DTP pharmacies through projects such as live broadcast of famous doctors and charity medication
    .
     
      ④ Carry out the construction of infusion centers, etc.
    Provide infusion services for drug injection patients through joint hospitals and self-built methods, so as to expand the sales of injection drugs in DTP pharmacies
    .
     
      DTP future outlook
      DTP future outlook
     
      Benchmarking to the United States, DTP has a lot of room for expansion
      Benchmarking to the United States, DTP has a lot of room for expansion
     
      In fact, in addition to the long-term benefits brought about by the continuous advancement of the pharmaceutical separation policy, the DTP pharmacy market is also facing unprecedented opportunities brought about by the development of the pharmaceutical market
    .
    As the research and development of market products such as drugs for chronic diseases gradually stabilizes, the main battlefield of future innovative drug research and development has shifted to the research and development of oncology drugs and rare drugs, which will inject continuous impetus into the DTP pharmacy market
    .
    Take the very mature American market for specialty drug pharmacies (the United States is not called DTP pharmacy, but specialty drug pharmacy) as an example, which can provide us with a good reference
    .
     
      As we all know, the US market has long been a market driven by innovative drugs.
    On the second day of the expiration of the patent protection period of all drugs, the price of all drugs will fall off a cliff due to the entry of generic drugs
    .
    China's pharmaceutical market is also changing to such a market
    .
    Driven by policies such as one-off evaluation of generic drugs and mass procurement, a pattern dominated by innovative drugs is taking shape
    .
    At the same time, the U.
    S.
    market is also a market for the separation of medicines.
    About 80% of the sales of medicines are done through retail channels.
    The separation of medicines is also an important direction for China's medical reform
    .
    Benchmarking the development of the US market has a relatively important reference for the development of China's DTP market
    .
     
      U.
    S.
    specialty medicines account for half of revenue, while China accounts for less than 4%
     
      In 2020, the overall U.
    S.
    retail pharmacy market’s operating revenue was US$319.
    3 billion, of which nearly half came from specialty drug pharmacies.
    Table 1 shows the revenue of TOP15 specialty drug pharmacies in the U.
    S.
    market in 2019, which adds up to US$135.
    5 billion, accounting for More than 80% of the entire specialty medicine market (also ordinary retail stores, mailing pharmacies, long-term care institutions and other channels)
    .
    The annual growth rate of the US specialty drug pharmacy market is about 5%, which is twice the growth rate of the general pharmacy market
    .
     
      The vigorous development of the specialty drug pharmacy market in the United States and the similar environment give us reason to believe in the future development prospects of the Chinese DTP pharmacy market
    .
    Although China's DTP pharmacy market is currently only about 19 billion yuan in scale, accounting for less than 4% of the overall pharmaceutical retail market, it has received extensive attention from the market
    .
     
      By 2024, China's DTP market will double again
     
      According to the estimation of Frost & Sullivan, a well-known consulting company, China's DTP market will grow to 38.
    3 billion yuan by 2024, and the growth rate is significantly higher than that of ordinary pharmaceutical retail
    .
    Figure 1 shows Frost & Sullivan's estimate of the DTP market size
    .
     
      Conclusion <<<
      Conclusion <<<
     
      The future is bright, and the road is tortuous
    .
    In the face of the promising DTP market, DTP practitioners should not encounter some small challenges and worry about nothing
    .
    When encountering a problem, it is necessary to analyze the problem and solve the problem, make a long-term plan, and gain a larger share in the future potential DTP market
    .
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.